While the potential role of anti-apoptotic proteins in treatment resistance is incompletely understood, MCL-1 is highly expressed in the majority of PTCL [14], a subset of which are MCL-1 dependent [15]. The gene discussed is MCL1; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.